While dysfunction of the IGF pathway appears to be critically important in colorectal cancer carcinogenesis, much work is still needed to develop the best approach to integrating anti-IGFR therapy into the treatment of colorectal cancer. This evidence concerns the gene IGF1R and colorectal cancer.